Stanford University
Stanford, California, 94303, United States
NCT Number: NCT05490277
The purpose of our study is to evaluate Vibrotactile Coordinated Reset stimulation (vCR) and its effects on motor ability within stroke patients. vCR will be administered with a device called the Vibrotactile (VT) Brain Glove. vCR is expected to provide patients with a non-invasive therapy to aid in recovery from a stroke. This study will include a dedicated sham arm that will aid in understanding true treatment effects from vCR.
Trial opening soon.
Get Notified18 year–80 year
All sexes
Interventional
Not applicable
Stanford, California, 94303, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive active vibrotactile coordinated reset (vCR) which sends gentle vibrations to the fingertips at a specific pattern. The purpose of the intervention is to test the efficacy of active vCR in comparison to sham vCR.
Participants will receive sham vibrotactile coordinated reset (vCR) which sends gentle vibrations to the fingertips at a specific pattern. The purpose of the intervention is to test the efficacy of active vCR in comparison to sham vCR.
Time frame: This clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment. The scale is comprised of five domains and there are 155 items in total. Scoring is based on direct observation of performance. Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible scale score is 226.
Time frame: This clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
The Neuro quality of life upper extremity short form test measures the functionality of upper extremities. This is a self-report questionnaire that has a Likert scale from 1 to 5, with 5 indicating no difficulties and 1 indicating unable to do. Total possible points are out of 40, with a higher score indicating better upper extremity abilities.
Time frame: This clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
The Barthel Index (BI) measures the extent to which somebody can function independently and has mobility in their activities of daily living (ADL) i.e. feeding, bathing, grooming, dressing, bowel control, bladder control, toileting, chair transfer, ambulation and stair climbing. Functional categories may be scored from 0 to 1, 0 to 2, or 0 to 3, depending on the item. Total scores range from 0 to 20, with lower scores indicating increased disability
Time frame: This clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
The Action Research Arm Test (ARAT) is a 19 item observational measure used by physical therapists and other health care professionals to assess upper extremity performance (coordination, dexterity and functioning) in stroke recovery, brain injury and multiple sclerosis populations.Items comprising the ARAT are categorized into four subscales (grasp, grip, pinch and gross movement). Task performance is rated on a 4-point scale, ranging from 0 (no movement) to 3 (movement performed normally). Scores on the ARAT may range from 0-57 points, with a maximum score of 57 points indicating better performance.
Time frame: This clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
This test is a measure walking ability with correlates to balance and fall risk. The patient is timed using a stopwatch and the patient is instructed to walk as quickly as possible for 3 meters. The test is scored as such: ≤ 10 seconds = normal ≤ 20 seconds = good mobility, can go out alone, mobile without gait aid ≤ 30 seconds = problems, cannot go outside alone, requires gait aid * A score of ≥ 14 seconds has been shown to indicate high risk of falls
Time frame: This clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
The Neuro quality of life lower extremity short form test measures the functionality of upper extremities. This is a self-report questionnaire that has a Likert scale from 1 to 5, with 5 indicating no difficulties and 1 indicating unable to do. Total possible points are out of 40, with a higher score indicating better lower extremity abilities.
Time frame: This clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
Patients receive vibratory stimuli on a finger and indicate when stimuli are felt by pressing a button.
Time frame: This clinical assessment will be done at baseline visit, three month visit, four month visit, seven month visit and eight month visit
Patients receive vibratory stimuli on two fingers either simultaneously or at different times and indicate the perceived timing by pressing a button.
Contact information is provided by the study sponsor or research team.
Stanford University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07725211
Brain Diseases, Cardiovascular Diseases
Bingoel, Center, Turkey (Türkiye)
View Trial DetailsNCT07686822
Chronic Stroke
Hangzhou, Zhejiang, China
View Trial DetailsNCT07597746
Balance, Chronic Stroke
View Trial DetailsNCT07459725
Brain Diseases, Cardiovascular Diseases
View Trial Details